Layer-by-layer surface modification of lipid nanocapsules

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 76, Issue 2, 2010, Pages 200-207

  Hirsjärvi, Samuli ^a   Qiao, Yan ^b   Royere, Audrey ^b   Bibette, Jérôme ^b   Benoit, Jean Pierre ^a  

^a UNIVERSITÉ D'ANGERS   (France)

^b PSL RESEARCH UNIVERSITY   (France)

Author keywords

Layer by layer coating; Lipid nanocapsules; Polyelectrolytes; Post insertion; Tangential flow filtration

Indexed keywords

CATIONIC SURFACTANT; CHITOSAN; DECANOIC ACID; DEXTRAN SULFATE; FONDAPARINUX; LABRAFAC WL 1349; LIPID; LIPOCHITOSAN; LIPOID S75 3; NANOCAPSULE; OCTANOIC ACID; POLYELECTROLYTE; SOLUTOL HS 15; STEARIC ACID DERIVATIVE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; FILTRATION; MOLECULAR INTERACTION; PARTICLE SIZE; PURIFICATION; SURFACE PROPERTY; SYNTHESIS; TECHNIQUE; ZETA POTENTIAL;

EID: 77957273003     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.07.010     Document Type: Article

References (57)

1. Decher G. Fuzzy nanoassemblies: toward layered polymeric multicomposites. Science 1997, 277:1232-1237.
2. Sukhorukov G.B., Donath E., Lichtenfeld H., Knippel E., Knippel M., Budde A., Möhwald H. Layer-by-layer self assembly of polyelectrolytes on colloidal particles. Colloids Surf. A 1998, 137:253-266.
3. Voigt A., Lichtenfeld H., Sukhorukov G.B., Zastrow H., Donath E., Bäumler H., Möhwald H. Membrane filtration for microencapsulation and microcapsules fabrication by layer-by-layer polyelectrolyte adsorption. Ind. Eng. Chem. Res. 1999, 38:4037-4043.
4. Shu S., Sun C., Zhang X., Wu Z., Wang Z., Li C. Hollow and degradable polyelectrolyte nanocapsules for protein drug delivery. Acta Biomater. 2010, 6:210-217.
5. Berth G., Voigt A., Dautzenberg H., Donath E., Möhwald H. Polyelectrolyte complexes and layer-by-layer capsules from chitosan/chitosan sulfate. Biomacromolecules 2002, 3:579-590.
6. Fan Y.F., Wang Y.N., Fan Y.G., Ma J.B. Preparation of insulin nanoparticles and their encapsulation with biodegradable polyelectrolytes via the layer-by-layer adsorption. Int. J. Pharm. 2006, 324:158-167.
7. Haidar Z.S., Hamdy R.C., Tabrizian M. Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes. Biomaterials 2008, 29:1207-1215.
8. Fukui Y., Fujimoto K. The preparation of sugar polymer-coated nanocapsules by the layer-by-layer deposition on the liposome. Langmuir 2009, 25:10020-10025.
9. Angelini G., Boncompagni S., De Maria P., Fontana A., Gasbarri C., Siani G. Kinetic evaluation of the effect of layer by layer deposition of polyelectrolytes on the stability of POPC liposomes. Colloids Surf. A 2008, 322:234-238.
10. Tan J.P.K., Wang Q., Tam K.C. Control of burst release from nanogels via layer by layer assembly. J. Control. Release 2008, 128:248-254.
11. Hirsjärvi S., Peltonen L., Hirvonen J. Layer-by-layer polyelectrolyte coating of low molecular weight poly(lactic acid) nanoparticles. Colloids Surf. B 2006, 49:93-99.
12. Fujimoto K., Toyoda T., Fukui Y. Preparation of bionanocapsules by the layer-by-layer deposition of polypeptides onto a liposome. Macromolecules 2007, 40:5122-5128.
13. Schwartz L., Seeley K. Introduction to tangential flow filtration for laboratory and process development applications 2003, Pall Life Sciences, Ann Arbor.
14. Heurtault B., Saulnier P., Pech B., Proust J.-E., Benoit J.-P. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm. Res. 2002, 19:875-880.
15. Heurtault B., Saulnier P., Benoit J.P., Proust J.E., Pech B., Joel R. Lipid nanocapsules, preparation method and use as medicine. Int. Patent 2001, WO0164328(A1).
16. Hoarau D., Delmas P., David S., Roux E., Leroux J.-C. Novel long-circulating lipid nanocapsules. Pharm. Res. 2004, 21:1783-1789.
17. Richard A., Barras A., Younes A.B., Monfilliette-Dupont N., Melnyk P. Minimal chemical modification of reductive end of dextran to produce an amphiphilic polysaccharide able to incorporate onto lipid nanocapsules. Bioconjugate Chem. 2008, 19:1491-1495.
18. Morille M., Montier T., Legras P., Carmoy N., Brodin P., Pitard B., Benoit J.-P., Passirani C. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. Biomaterials 2010, 31:321-329.
19. Morille M., Passirani C., Letrou-Bonneval E., Benoit J.P., Pitard B. Galactosylated DNA lipid nanocapsules for efficient hepatocyte targeting. Int. J. Pharm. 2009, 379:293-300.
20. Béduneau A., Hindré F., Clavreul A., Leroux J.-C., Saulnier P., Benoit J.-P. Brain targeting using novel lipid nanovectors. J. Control. Release 2008, 126:44-49.
21. Béduneau A., Saulnier P., Hindré F., Clavreul A., Leroux J.-C., Benoit J.-P. Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments. Biomaterials 2007, 28:4978-4990.
22. Zou J., Saulnier P., Perrier T., Zhang Y., Manninen T., Toppila E., Pyykkö I. Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation. J. Biomed. Mater. Res. B 2008, 87B:10-18.
23. Kumar M.N.V.R., Muzzarelli R.A.A., Muzzarelli C., Sashiwa H., Domb A.J. Chitosan chemistry and pharmaceutical perspectives. Chem. Rev. 2004, 104:6017-6084.
24. Hirano S., Ohe Y., Ono H. Selective N-acylation of chitosan. Carbohydr. Res. 1976, 47:315-320.
25. Lee D.-W., Powers K., Baney R. Physicochemical properties and blood compatibility of acylated chitosan nanoparticles. Carbohydr. Polym. 2004, 58:371-377.
26. Chen Y., Mohanraj V.J., Parkin J.E. Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide. Lett. Pept. Sci. 2003, 10:621-629.
27. Peltier S., Oger J.-M., Lagarce F., Couet W., Benoit J.-P. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules. Pharm. Res. 2006, 23:1243-1250.
28. Heurtault B., Saulnier P., Pech B., Venier-Julienne M.-C., Proust J.-E., Phan-Tan-Luu R., Benoit J.-P. The influence of lipid nanocapsule composition on their size distribution. Eur. J. Pharm. Sci. 2003, 18:55-61.
29. Muzzarelli R.A.A. Colorimetric determination of chitosan. Anal. Biochem. 1998, 260:255-257.
30. Khokhlov V.Y., Selemenev V.F., Khokhlova O.N., Shcherbinin R.L. Heparin determination by spectrophotometric and photocolorimetric methods. Pharm. Chem. J. 1999, 33:450-451.
31. U.S. Pharmacopeia. Vol. 29 (2006), Rockville, MD.
32. Hirano S., Ohe Y. A facile N-acylation of chitosan with carboxylic anhydrides in acidic solutions. Carbohydr. Res. 1975, 41:C1-C2.
33. Hirano S., Yamaguchi Y., Kamiya M. Novel N-saturated-fatty-acyl derivatives of chitosan soluble in water and in aqueous acid and alkaline solutions. Carbohydr. Polym. 2002, 48:203-207.
34. Fenske D.B., Palmer L.R., Chen T., Wong K.F., Cullis P.R. Cationic poly(ethyleneglycol) lipids incorporated into pre-formed vesicles enhance binding and uptake to BHK cells. Biochim. Biophys. Acta 2001, 1512:259-272.
35. Moreira J.N., Ishida T., Gaspar R., Allen T.M. Use of the post-insertion technique to insert peptide ligands into pre-formulated stealth liposomes with retention of binding activity and cytotoxicity. Pharm. Res. 2002, 19:265-269.
36. Sou K., Endo T., Takeoka S., Tsuchida E. Poly(ethylene glycol)-modification of the phospholipid vesicles by using the spontaneous incorporation of poly(ethylene glycol)-lipid into the vesicles. Bioconjugate Chem. 2000, 11:372-379.
37. Uster P.S., Allen T.M., Daniel B.E., Mendez C.J., Newman M.S., Zhu G.Z. Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time. FEBS Lett. 1996, 386:243-246.
38. 188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution. Eur. J. Nuclear Med. Mol. Imag. 2006, 33:602-607.
39. Juang R.-S., Tseng R.-L., Wu F.-C., Lin S.-J. Use of chitin and chitosan in lobster shell wastes for color removal from aqueous solutions. J. Environ. Sci. Health A 1996, 31:325-338.
40. Dalwadi G., Benson H., Chen Y. Comparison of diafiltration and tangential flow filtration for purification of nanoparticle suspensions. Pharm. Res. 2005, 22:2152-2162.
41. Dalwadi G., Sunderland B. Comparison and validation of drug loading parameters of PEGylated nanoparticles purified by a diafiltration centrifugal device and tangential flow filtration. Drug Dev. Ind. Pharm. 2008, 34:1331-1342.
42. Dalwadi G., Sunderland V.B. Purification of PEGylated nanoparticles using tangential flow filtration (TFF). Drug Dev. Ind. Pharm. 2007, 33:1030-1039.
43. de Jaeghere F., Allémann E., Feijen J., Kissel T., Doelker E., Gurny R. Freeze-drying and lyopreservation of diblock and triblock poly(lactic acid)-poly(ethylene oxide) (PLA-PEO) copolymer nanoparticles. Pharm. Dev. Technol. 2000, 5:473-483.
44. de Jaeghere F., Allémann E., Leroux J.-C., Stevels W., Feijen J., Doelker E., Gurny R. Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake. Pharm. Res. 1999, 16:859-866.
45. Hirsjärvi S., Peltonen L., Hirvonen J. Effect of sugars, surfactant, and tangential flow filtration on the freeze-drying of poly(lactic acid) nanoparticles. AAPS Pharm. Sci. Technol. 2009, 10:488-494.
46. Limayem I., Charcosset C., Fessi H. Purification of nanoparticle suspensions by a concentration/diafiltration process. Sep. Purif. Technol. 2004, 38:1-9.
47. Saez A., Guzmán M., Molpeceres J., Aberturas M.R. Freeze-drying of polycaprolactone and poly(d,l-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. Eur. J. Pharm. Biopharm. 2000, 50:379-387.
48. Chen Y., Mohanraj V.J., Wang F., Benson H.A.E. Designing chitosan-dextran sulfate nanoparticles using charge ratios. AAPS Pharm. Sci. Technol. 2007, 8:article 98.
49. Dubas S.T., Schlenoff J.B. Polyelectrolyte multilayers containing a weak polyacid: construction and deconstruction. Macromolecules 2001, 34:3736-3740.
50. Messmore H.L.J., Wehrmacher W.H., Coyne E., Fareed J. Heparin to pentasaccharide and beyond: the end is not in sight. Semin. Thromb. Hemost. 2004, 30:81-88.
51. Pineo G., Hull R., Marder V. Oral delivery of heparin: SNAC and related formulations. Best Pract. Res. Clin. Haematol. 2004, 17:153-160.
52. Kim B.-S., Smith R.C., Poon Z., Hammond P.T. MAD (multiagent delivery) nanolayer: delivering multiple therapeutics from hierarchically assembled surface coatings. Langmuir 2009, 25:14086-14092.
53. Fiebrig I., Harding S.E., Rowe A.J., Hyman S.C., Davis S.S. Transmission electron microscopy studies on pig gastric mucin and its interactions with chitosan. Carbohydr. Polym. 1995, 28:239-244.
54. Paria S., Khilar K.C. A review on experimental studies of surfactant adsorption at the hydrophilic solid-water interface. Adv. Colloid Interface Sci. 2004, 110:75-95.
55. Nadar S.K., Goyal D., Shantsila E., Banerjee P., Lip G.Y.H. Fondaparinux: an overview. Exp. Rev. Cardiovasc. Ther. 2009, 7:577-585.
56. Roger E., Lagarce F., Benoit J.P. The gastrointestinal stability of lipid nanocapsules. Int. J. Pharm. 2009, 379:260-265.
57. Lamprecht A., Saumet J.-L., Roux J., Benoit J.-P. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment. Int. J. Pharm. 2004, 278:407-414.